Centrica plc has announced that two of its executive directors, Christopher O'Shea and Russell O'Brien, have acquired Centrica ordinary shares under the company's Share Incentive Plan. The notifications were made pursuant to Article 19 of the Market Abuse Regulation. The transactions were conducted on September 11, 2023, with Equiniti Share Plan Trustees Limited acting on behalf of the directors. The shares were acquired at a price of £1.6302 for 92 partnership shares and £1.590833333 for 22 matching shares. The aggregated volume of shares acquired was 114, with a total value of £184.98. The transactions took place on the London Stock Exchange for partnership shares and outside a trading venue for matching shares. Centrica plc is listed on the London Stock Exchange and has its registered office in Windsor, Berkshire.